Results 71 to 80 of about 57,206 (164)
Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies
ABSTRACT Objective To characterize whole‐body intramuscular fat distribution pattern in patients with sarcoglycanopathies and explore correlations with disease severity, duration and age at onset. Methods Retrospective, cross‐sectional, multicentric study enrolling patients with variants in one of the four sarcoglycan genes who underwent whole‐body ...
Laura Costa‐Comellas +39 more
wiley +1 more source
Objective Targeted therapies for facioscapulohumeral muscular dystrophy (FSHD) are progressing through clinical trials. Electrical impedance myography (EIM) provides a noninvasive biomarker of muscle composition that may be valuable especially in early phase trials. This study evaluated EIM data from a multicenter FSHD cohort over 24 months.
Karlien Mul +68 more
wiley +1 more source
Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment
BACKGROUND: In the Facioscapulohumeral muscular dystrophy (FSHD), the association of ankle muscle impairment with knee, hip and abdominal weakness causes complex alterations of static (postural) and dynamic (walking) balance, increasing the risk of ...
Padua, Luca +3 more
core
Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral (FSH) muscular dystrophy is the third most common dystrophy, after myotonic dystrophy and the dystrophinopathies (Duchenne and Becker), with a prevalence of approximately 1 in 20,000.
Benatar, Michael
core +1 more source
Facioscapulohumeral dystrophy (FSHD) is an autosomal-dominant muscular disorder associated with a short ...
Guazzi, Giancarlo +7 more
core +1 more source
Molecular diagnosis of facioscapulohumeral muscular dystrophy [review]
Facioscapulohumeral muscular dystrophy (FSHD) is the third most common inherited neuromuscular disorder after Duchenne muscular dystrophy and myotonic dystrophy.
Upadhyaya, Meena, Cooper, David Neil
core +1 more source
Symptomatic treatment in facioscapulohumeral dystrophy (FSHD): a case study
Facioscapulohumeral dystrophy (FSHD) represents the third most prevalent form of muscular dystrophy observed in the adult population, exhibiting an overall incidence of over 1 in 10,000 individuals.
Magdalena Bitner-Bieleszuk
doaj +1 more source
Facioscapulohumeral muscular dystrophy (FSHD) is a muscular dystrophy that can affect individuals of all age groups. Its prevalence is reported to be 0.4-1 in 10,000 people. Because of the low occurrence of FSHD, anaesthetic management is primarily based
Mete Manici +4 more
doaj +1 more source
The relative frequency of common neuromuscular diagnoses in a reference center
The diagnostic procedure in neuromuscular patients is complex. Knowledge of the relative frequency of neuromuscular diseases within the investigated population is important to allow the neurologist to perform the most appropriate diagnostic tests ...
Ana Cotta +12 more
doaj +1 more source
Elderly Onset of Weakness in Facioscapulohumeral Muscular Dystrophy
A 77-year-old male is presented. He had onset of proximal weakness 10 years earlier. His course was slowly progressive. Despite having phenotypic features of facioscapulohumeral muscular dystrophy (FSH), genetic testing for this was delayed because of ...
Dominic B. Fee
doaj +1 more source

